文献速递中枢神经肿瘤放疗姑息放疗与转移瘤

胶质母细胞瘤患者血糖水平与中枢味觉系统放疗剂量呈正相关

Positive correlation between blood glucose and radiotherapy doses to the central gustatory system in Glioblastoma Multiforme patients.
PubMed 文献 · Radiat Oncol · 2019-06-07

结果显示总GS的平均EQD2 Dmean为36.0Gy,总GS剂量越高,最大血糖值有升高趋势(b=1.9,R2=0.103,p=0.06),提示GBM患者血糖水平与中枢GS放疗剂量直接相关。

要点

  • 总GS的平均EQD2 Dmean为36.0Gy(±8.6Gy)。
  • 总GS剂量越高,最大血糖值有升高趋势(b=1.9,R2=0.103,p=0.06)。

核心结论

  • GBM患者血糖水平与中枢味觉系统接受的放疗剂量呈直接相关。
  • 接受放疗的GBM患者应在放疗期间及放疗后密切监测血糖变化。

研究设计与样本

  • 女性占59.5%,男性占40.5%,中位年龄64.3岁(范围27.4-85.6)。
  • 评估2型糖尿病(DM2)病史、血糖水平及地塞米松(DEXA)用药。
  • 在配准至计划CT的MRI上勾画中枢味觉结构,并将GS剂量转换为2Gy分次的等效剂量(EQD2)。

主要发现

  • DM2患者平均血糖为192.8 mg/dl(±24.4),非DM2患者为145.7 mg/dl(±39.5),差异有统计学意义(p=0.01)。
  • 每日DEXA用量在DM2患者为7.9 mg/d(±1.9),非DM2患者为9.3 mg/dl(±5.7),差异无统计学意义(p=0.29)。
  • 总GS的EQD2 Dmean为36.0Gy(±8.6Gy)。
  • 总GS放疗剂量越高,最大血糖值有升高趋势(b=1.9,R2=0.103,p=0.06)。

关键数值与推荐

  • 中枢味觉系统分析结构包括:孤束及孤束核、丘脑腹后内侧核、中央后回舌感觉区、岛叶前部、额盖、杏仁核、下丘脑。
  • 所有GS剂量均转换为EQD2进行分析。

临床怎么用

  • GBM患者放疗期间及放疗后应密切监测血糖变化。
  • 对中枢味觉系统接受较高放疗剂量的GBM患者,尤需关注血糖升高风险。

局限性

  • 总GS剂量与最大血糖值的关系仅为趋势性(p=0.06),未达统计学显著性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study was to assess the correlations between the levels of blood glucose (BG) and the dose of radiation therapy (RT) to the central gustatory system (GS) in glioblastoma multiforme (GBM) patients. METHODS: Thirty-seven GBM patients with regular blood glucose measurements were investigated retrospectively. 59.5% were female and 40.5% male with a median age of 64.3 years (range 27.4-85.6). Diabetes mellitus type 2 (DM2) history, BG levels and dexamethasone (DEXA) medication were assessed. The analyzed central gustatory structures were: solitary tract and nucleus, ventral posteromedial nucleus of the thalamus, sensory tongue area of the postcentral gyrus, anterior part of the insula, frontal operculum, amygdala, hypothalamus. These structures were delineated on magnetic resonance tomographies (MRIs) registered to planning-CTs. All GS doses were transformed in equivalent doses in 2 Gy fraction (EQD2). RESULTS: Twenty one patients (56.8%) had at least one BG values over 200 mg/dl during RT. There was a difference between average BG in DM2: 192.8 mg/dl (±24.4) and non-DM2 patients: 145.7 mg/dl (±39.5; p = 0.01) but no significant difference in daily DEXA medication - DM2 patients: 7.9 mg/d (±1.9) vs. non-DM2: 9.3 mg/dl (±5.7; p = 0.29). The EQD2 Dmean to the total GS was 36.0Gy (±8.6 Gy). There was a tendency for a higher increase in maximum BG values with more radiation dose to the total GS (b = 1.9, R2 = 0.103, p = 0.06). CONCLUSION: BG levels in GBM patients are in direct correlation to the dose of RT applied to the central GS. GBM patients that undergo RT should thus be closely monitored for changes in BG levels during and after the radiation.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Duma MN, Oszfolk NI, Boeckh-Behrens T, et al. Positive correlation between blood glucose and radiotherapy doses to the central gustatory system in Glioblastoma Multiforme patients. Radiat Oncol. 2019. PMID: 31174561. doi:10.1186/s13014-019-1311-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。